Skip to Main Content
Henry Han, M.D.

Henry Han, M.D.

Assistant Professor

School
Medical School
Department
Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Henry B. Han, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in vascular and cardiovascular medicine.

    Dr. Han earned his medical degree at UT Southwestern Medical School. He completed a residency in internal medicine and received advanced training through fellowships in vascular medicine and cardiovascular medicine at the University of Michigan. Certified by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2024.

    Dr. Han's clinical interests focus on the comprehensive management of vascular disorders, including venous thromboembolism and aortopathies.

    In addition to his clinical expertise, he is actively engaged in health services research, particularly in the areas of thrombosis and antithrombotic management. His research has contributed to insights into the management of venous thromboembolism, especially in the context of hospitalized patients and those with complex cardiovascular conditions.

    Dr. Han's research is driven by a passion for improving health care delivery and patient safety through evidence-based practices. His work has been published in leading journals, including Journal of the American College of CardiologyVascular Medicine and Thrombosis Research. He is a recognized member of several professional societies, including the American College of Cardiology and the Society for Vascular Medicine.

  • Education
    Medical School
    UT Southwestern Medical School (2017)
    Residency
    University of Michigan Hospitals (2020), Internal Medicine
    Fellowship
    University of Michigan (2021), Vascular Medicine
    Fellowship
    University of Michigan (2024), Cardiovascular Disease
  • Research Interest
    • Antithrombotic medication management
  • Publications

    Star Featured Publications

    Featured
    Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
    Hyder SN, Han HB, Ash S, Horne BD, Stevens SM, Woller SC, Barnes GD, Thromb Res 2023 Jul 227 45-50
    Diagnostic patterns and stress testing trends after implementing high-sensitivity troponin assay.
    Yeow RY, Han H, Henderson J, Grzyb K, Johnson M, Dibble ER, Gupta A, Giacherio D, Froehlich J, Somand D, Flanders SA, Barnes GD, Am J Manag Care 2021 09 27 9 e293-e300
    PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19.
    Han H, Barnes GD, Vasc Med 2021 Aug 26 4 434-436
    Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process.
    Han H, Chung G, Sippola E, Chen W, Morgan S, Renner E, Ruff A, Sales A, Kurlander J, Barnes GD, Res Pract Thromb Haemost 2021 Jul 5 5 e12558
    Effect of Extended-Release Niacin on Carotid Intima Media Thickness, Reactive Hyperemia, and Endothelial Progenitor Cell Mobilization: Insights From the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial.
    Guerra A, Rangan BV, Coleman A, Xu H, Kotsia A, Christopoulos G, Sosa A, Chao H, Han H, Abdurrahim G, Roesle M, de Lemos JA, McGuire DK, Packer M, Banerjee S, Brilakis ES J Invasive Cardiol 2015 Dec 27 12 555-60
    Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.
    Sosa A, Chao H, Guerra A, Han H, Christopoulos G, Christakopoulos GE, Tarar MN, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Banerjee S, Brilakis ES Int. J. Cardiol. 2015 Mar 186 261-263
  • Books

    Featured